These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 26936278)

  • 21. [FEV vs FIV, air need vs pulmonary function. Thereupon COPD diagnosis is made].
    Westphal K
    MMW Fortschr Med; 2003 May; 145(22):20. PubMed ID: 12866269
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pharmacologic treatment of stable COPD].
    Yamaguchi K
    Nihon Kokyuki Gakkai Zasshi; 2004 Aug; 42(8):710-6. PubMed ID: 15455943
    [No Abstract]   [Full Text] [Related]  

  • 23. COPD Management in the Primary Care Setting.
    Skolnik N; Kaplan AG; Lake T; Hayden ML; Hanania NA
    J Fam Pract; 2018 Oct; 67(10 Suppl):S27-S32. PubMed ID: 30423008
    [No Abstract]   [Full Text] [Related]  

  • 24. Gas exchange response to short-acting beta2-agonists in chronic obstructive pulmonary disease severe exacerbations.
    Polverino E; Gómez FP; Manrique H; Soler N; Roca J; Barberà JA; Rodríguez-Roisin R
    Am J Respir Crit Care Med; 2007 Aug; 176(4):350-5. PubMed ID: 17431221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival with tiotropium compared to long-acting Beta-2-agonists in Chronic Obstructive Pulmonary Disease.
    Gershon AS; Wang L; To T; Luo J; Upshur RE
    COPD; 2008 Aug; 5(4):229-34. PubMed ID: 18671148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions between corticosteroids and beta2-agonists in asthma and chronic obstructive pulmonary disease.
    Johnson M
    Proc Am Thorac Soc; 2004; 1(3):200-6. PubMed ID: 16113435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimizing chronic obstructive pulmonary disease management in primary care.
    Yawn BP
    South Med J; 2011 Feb; 104(2):121-7. PubMed ID: 21079536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM; White CM; Coleman CI
    Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical practice. Outpatient management of severe COPD.
    Niewoehner DE
    N Engl J Med; 2010 Apr; 362(15):1407-16. PubMed ID: 20393177
    [No Abstract]   [Full Text] [Related]  

  • 30. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.
    Hanania NA
    Pulm Pharmacol Ther; 2008; 21(3):540-50. PubMed ID: 18280761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of bronchodilators in chronic obstructive pulmonary disease.
    Weder MM; Donohue JF
    Semin Respir Crit Care Med; 2005 Apr; 26(2):221-34. PubMed ID: 16088439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial.
    Baumgartner RA; Hanania NA; Calhoun WJ; Sahn SA; Sciarappa K; Hanrahan JP
    Clin Ther; 2007 Feb; 29(2):261-78. PubMed ID: 17472819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Roflumilast added to triple therapy in patients with severe COPD: a real life study.
    Muñoz-Esquerre M; Diez-Ferrer M; Montón C; Pomares X; López-Sánchez M; Huertas D; Manresa F; Dorca J; Santos S
    Pulm Pharmacol Ther; 2015 Feb; 30():16-21. PubMed ID: 25445930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Innovations to achieve excellence in COPD diagnosis and treatment in primary care.
    Fromer L; Barnes T; Garvey C; Ortiz G; Saver DF; Yawn B
    Postgrad Med; 2010 Sep; 122(5):150-64. PubMed ID: 20861599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variation in adherence with Global Initiative for Chronic Obstructive Lung Disease (GOLD) drug therapy guidelines: a retrospective actuarial claims data analysis.
    Fitch K; Iwasaki K; Pyenson B; Plauschinat C; Zhang J
    Curr Med Res Opin; 2011 Jul; 27(7):1425-9. PubMed ID: 21599554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [COPD routine management in France: are guidelines used in clinical practice?].
    Jebrak G;
    Rev Mal Respir; 2010; 27(1):11-8. PubMed ID: 20146947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Costs of chronic obstructive pulmonary disease in relation to compliance with guidelines: a study in the primary care setting.
    Miravitlles M; Sicras A; Crespo C; Cuesta M; Brosa M; Galera J; Lahoz R; Lleonart M; Riera MI
    Ther Adv Respir Dis; 2013 Jun; 7(3):139-50. PubMed ID: 23653458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coverage of and factors associated with pneumococcal vaccination in chronic obstructive pulmonary disease.
    Carreño-Ibáñez LV; Esteban-Vasallo MD; Domínguez-Berjón MF; Astray-Mochales J; González Del Yerro C; Iniesta-Fornies D; Gascón-Sancho MJ; Jiménez-García R
    Int J Tuberc Lung Dis; 2015 Jun; 19(6):735-41. PubMed ID: 25946369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Responsible prescribing for asthma and COPD.
    Pearce L
    Nurs Times; 2012 Nov 13-19; 108(46):12, 14, 16. PubMed ID: 23240219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heartbeat: Heart failure and obstructive lung disease: are beta-blockers underused?
    Otto CM
    Heart; 2016 Dec; 102(23):1855-1856. PubMed ID: 27836944
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.